CL2008002135A1 -
Inhalable powders containing the lactose excipient, a salt of salmeterol addition and a tiotropium salt having an aw value of between 0.05 and 0.5; pharmaceutical composition that includes it; process for preparing said powders; inhalation kit
- Google Patents
Inhalable powders containing the lactose excipient, a salt of salmeterol addition and a tiotropium salt having an aw value of between 0.05 and 0.5; pharmaceutical composition that includes it; process for preparing said powders; inhalation kit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim IntfiledCriticalBoehringer Ingelheim Int
Publication of CL2008002135A1publicationCriticalpatent/CL2008002135A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Polvos inhalables que contienen el excipiente lactosa, una sal de adición de salmeterol y una sal de tiotropio que presenta un valor de aw de entre 0,05 y 0,5; composición farmacéutica que lo comprende; procedimiento de preparación de dichos polvos; kit de inhalación.Inhalable powders containing the lactose excipient, a salmeterol addition salt and a tiotropium salt having an aw value of between 0.05 and 0.5; pharmaceutical composition comprising it; process for preparing said powders; inhalation kit
CL2008002135A2007-07-212008-07-18
Inhalable powders containing the lactose excipient, a salt of salmeterol addition and a tiotropium salt having an aw value of between 0.05 and 0.5; pharmaceutical composition that includes it; process for preparing said powders; inhalation kit
CL2008002135A1
(en)
Inhalable powders containing the lactose excipient, a salt of salmeterol addition and a tiotropium salt having an aw value of between 0.05 and 0.5; pharmaceutical composition that includes it; process for preparing said powders; inhalation kit
Compounds derived from cyanoisoquinoline; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound for the treatment of a drug addiction, in the treatment of a neurodegenerative disorder, such as Alzheimer's, Parkinson's, dementia, among others.
COMPOUNDS DERIVED FROM 6-OXO-6,7-DIHIDRO-5H-DIBENZO- [B, D] AZEPIN-7-ILO; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF ALZHEIMER OR CANCER DISEASE.
Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
Inhalable powders containing the lactose excipient, a salt of salmeterol addition and a tiotropium salt having an aw value of between 0.05 and 0.5; pharmaceutical composition that includes it; process for preparing said powders; inhalation kit